MedPath

Efficacy of conbination therapy of DPP4-inhibitor and alpha-GI for type-2 diabetes patient.

Not Applicable
Conditions
type-2 diabetes mellitus
Registration Number
JPRN-UMIN000008051
Lead Sponsor
Third Department of Internal Medicine, Tokyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

contraindication for taking alogliptin contraindication for taking acarbose contraindication for taking miglitol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath